Korea Develops Cloned Pigs that Can Produce Anticancer Assist
2019-03-25 15:26:26
According to the report of Korea’s “Korean Daily†website on the 24th, researchers from South Korea’s Chungnam University and other institutions have newly created a cloned pig that can produce a protein that can be used as an adjunct anti-cancer therapeutic agent.
It is reported that when this cloned pig matures, its secreted milk will contain a protein called "granulocyte-macrophage colony stimulating factor" (GM-CSF). GM-CSF is a small amount of protein secreted by the human body and has the effect of promoting leukocyte production. It can alleviate leukocyte deficiency when treating leukemia, anemia, and cancer. According to experts, this protein is currently priced at up to $600,000 per gram.
Pang Chang-sik, head of the Research Center for Transgenic Cloning Pigs at Chungnam National University in South Korea, said that they are collaborating with a Korean biotechnology company to produce such cloned pigs. The researchers first implanted the human GM-CSF gene in sow somatic cells and used cloning techniques to grow approximately 1600 porcine embryos. These embryos were then implanted into the uterus of a surrogate sow, which eventually yielded four GM-genes. Cloning pigs of CSF protein.
The report said that Korean researchers have applied for a patent in Korea on this outcome. If the technology is successfully commercialized, it is estimated that it will generate an average annual income of about 600 million U.S. dollars. However, experts pointed out that the commercialization of this technology may still take a long time.
Park Chang-chi said that even if the economics of cloning pigs are confirmed, clinical studies must be conducted and they need to be approved by the Korean authorities. It may take 10 to 15 years for commercialization to be realized.
It is reported that when this cloned pig matures, its secreted milk will contain a protein called "granulocyte-macrophage colony stimulating factor" (GM-CSF). GM-CSF is a small amount of protein secreted by the human body and has the effect of promoting leukocyte production. It can alleviate leukocyte deficiency when treating leukemia, anemia, and cancer. According to experts, this protein is currently priced at up to $600,000 per gram.
Pang Chang-sik, head of the Research Center for Transgenic Cloning Pigs at Chungnam National University in South Korea, said that they are collaborating with a Korean biotechnology company to produce such cloned pigs. The researchers first implanted the human GM-CSF gene in sow somatic cells and used cloning techniques to grow approximately 1600 porcine embryos. These embryos were then implanted into the uterus of a surrogate sow, which eventually yielded four GM-genes. Cloning pigs of CSF protein.
The report said that Korean researchers have applied for a patent in Korea on this outcome. If the technology is successfully commercialized, it is estimated that it will generate an average annual income of about 600 million U.S. dollars. However, experts pointed out that the commercialization of this technology may still take a long time.
Park Chang-chi said that even if the economics of cloning pigs are confirmed, clinical studies must be conducted and they need to be approved by the Korean authorities. It may take 10 to 15 years for commercialization to be realized.
Ginger Herbal Medicine,Ginger Food,Ginger Root,Ginger Powder
Yirun Agricultural Cooperative , http://www.yiruncn.com